Review





Similar Products

96
ATCC human ec cell lines
Human Ec Cell Lines, supplied by ATCC, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/human ec cell lines/product/ATCC
Average 96 stars, based on 1 article reviews
human ec cell lines - by Bioz Stars, 2026-05
96/100 stars
  Buy from Supplier

94
ATCC hepatocellular carcinoma cells
Hepatocellular Carcinoma Cells, supplied by ATCC, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/hepatocellular carcinoma cells/product/ATCC
Average 94 stars, based on 1 article reviews
hepatocellular carcinoma cells - by Bioz Stars, 2026-05
94/100 stars
  Buy from Supplier

94
R&D Systems ca
Ca, supplied by R&D Systems, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/ca/product/R&D Systems
Average 94 stars, based on 1 article reviews
ca - by Bioz Stars, 2026-05
94/100 stars
  Buy from Supplier

ovcar  (ATCC)
94
ATCC ovcar
Ovcar, supplied by ATCC, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/ovcar/product/ATCC
Average 94 stars, based on 1 article reviews
ovcar - by Bioz Stars, 2026-05
94/100 stars
  Buy from Supplier

86
Procell Inc human cc cell line ca ski
Human Cc Cell Line Ca Ski, supplied by Procell Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/human cc cell line ca ski/product/Procell Inc
Average 86 stars, based on 1 article reviews
human cc cell line ca ski - by Bioz Stars, 2026-05
86/100 stars
  Buy from Supplier

95
Sino Biological t62 229e cov np antibody sino biological cas
T62 229e Cov Np Antibody Sino Biological Cas, supplied by Sino Biological, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/t62 229e cov np antibody sino biological cas/product/Sino Biological
Average 95 stars, based on 1 article reviews
t62 229e cov np antibody sino biological cas - by Bioz Stars, 2026-05
95/100 stars
  Buy from Supplier

hpv 10  (ATCC)
94
ATCC hpv 10
( A , B ) Expression per Pten pc−/− LSC med cell subpopulation ( A ) and UMAP projection ( B ) of Pim1 . ( C , D ) Number ( C ) and size ( D ) of organoids generated from sorted Pten pc−/− LSC med cells after 10 days of culture in medium containing DMSO or 1 nM JQ-1 and 1 nM CX-6258, alone or combined, as indicated. Data were normalized to the control (DMSO) condition (biological replicates, n = 5 independent experiments). ** p < 0.01; *** p < 0.001; **** p < 0.0001 (one-way ANOVA and Dunnett post hoc test). Exact p values are reported in Appendix Table . ( E , F ) Enrichment of various epithelial cell signatures ( E ) and LSC med subpopulation signatures ( F ) in <t>HPV-10,</t> PC-3, DU145, LNCaP, and 22Rv1 cell lines (Data Ref: Wang et al, ). ( G ) Enrichment of CRPC-AR, CRPC-WNT, CRPC-NE, and CRPC-SCL human tumoral subtypes signatures (Dataset ) in HPV-10, PC-3, DU145, LNCaP, and 22Rv1 cell lines. ( H ) Human HPV-10 cells were treated for 72 h with 1 µM JQ-1 and 1 µM CX-6258, alone or combined (as indicated), then the number of adherent cells was counted (biological replicates, n = 4 independent experiments). The data were normalized to the control condition (DMSO). ** p < 0.01; *** p < 0.001 (one-way ANOVA and Dunnett post hoc test). Exact p values are reported in Appendix Table . ( I ) Images of HPV-10 cells after 72 h of treatment. ( J ) The viability of HPV-10 cells (adherent + in suspension) was determined by trypan blue staining (biological replicates, n = 4 independent experiments). ns not significant; * p < 0.05 (one-way ANOVA and Dunnett post hoc test). Exact p values are reported in Appendix Table . ( K , L ) Same as ( H , J ) with PC-3 cells (biological replicates, n = 4 independent experiments). ns not significant; * p < 0.05, ** p < 0.01; *** p < 0.001 (one-way ANOVA and Dunnett post hoc test). Exact p values are reported in Appendix Table . ( M ) Tumorsphere-forming capacity of HPV-10 cells in medium containing DMSO or 1 µM JQ-1 and 1 µM CX - 6258, alone or combined as indicated. Data were normalized to the DMSO condition (biological replicates, n = 3 independent experiments). *** p < 0.001 (one-way ANOVA and Dunnett post hoc test). Exact p values are reported in Appendix Table . All error bars in this figure represent SD. .
Hpv 10, supplied by ATCC, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/hpv 10/product/ATCC
Average 94 stars, based on 1 article reviews
hpv 10 - by Bioz Stars, 2026-05
94/100 stars
  Buy from Supplier

93
Tocris bis 4hydroxyphenyl propionitrile dpn cas no 1428 67 7
( A , B ) Expression per Pten pc−/− LSC med cell subpopulation ( A ) and UMAP projection ( B ) of Pim1 . ( C , D ) Number ( C ) and size ( D ) of organoids generated from sorted Pten pc−/− LSC med cells after 10 days of culture in medium containing DMSO or 1 nM JQ-1 and 1 nM CX-6258, alone or combined, as indicated. Data were normalized to the control (DMSO) condition (biological replicates, n = 5 independent experiments). ** p < 0.01; *** p < 0.001; **** p < 0.0001 (one-way ANOVA and Dunnett post hoc test). Exact p values are reported in Appendix Table . ( E , F ) Enrichment of various epithelial cell signatures ( E ) and LSC med subpopulation signatures ( F ) in <t>HPV-10,</t> PC-3, DU145, LNCaP, and 22Rv1 cell lines (Data Ref: Wang et al, ). ( G ) Enrichment of CRPC-AR, CRPC-WNT, CRPC-NE, and CRPC-SCL human tumoral subtypes signatures (Dataset ) in HPV-10, PC-3, DU145, LNCaP, and 22Rv1 cell lines. ( H ) Human HPV-10 cells were treated for 72 h with 1 µM JQ-1 and 1 µM CX-6258, alone or combined (as indicated), then the number of adherent cells was counted (biological replicates, n = 4 independent experiments). The data were normalized to the control condition (DMSO). ** p < 0.01; *** p < 0.001 (one-way ANOVA and Dunnett post hoc test). Exact p values are reported in Appendix Table . ( I ) Images of HPV-10 cells after 72 h of treatment. ( J ) The viability of HPV-10 cells (adherent + in suspension) was determined by trypan blue staining (biological replicates, n = 4 independent experiments). ns not significant; * p < 0.05 (one-way ANOVA and Dunnett post hoc test). Exact p values are reported in Appendix Table . ( K , L ) Same as ( H , J ) with PC-3 cells (biological replicates, n = 4 independent experiments). ns not significant; * p < 0.05, ** p < 0.01; *** p < 0.001 (one-way ANOVA and Dunnett post hoc test). Exact p values are reported in Appendix Table . ( M ) Tumorsphere-forming capacity of HPV-10 cells in medium containing DMSO or 1 µM JQ-1 and 1 µM CX - 6258, alone or combined as indicated. Data were normalized to the DMSO condition (biological replicates, n = 3 independent experiments). *** p < 0.001 (one-way ANOVA and Dunnett post hoc test). Exact p values are reported in Appendix Table . All error bars in this figure represent SD. .
Bis 4hydroxyphenyl Propionitrile Dpn Cas No 1428 67 7, supplied by Tocris, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/bis 4hydroxyphenyl propionitrile dpn cas no 1428 67 7/product/Tocris
Average 93 stars, based on 1 article reviews
bis 4hydroxyphenyl propionitrile dpn cas no 1428 67 7 - by Bioz Stars, 2026-05
93/100 stars
  Buy from Supplier

94
R&D Systems human ca ii
( A , B ) Expression per Pten pc−/− LSC med cell subpopulation ( A ) and UMAP projection ( B ) of Pim1 . ( C , D ) Number ( C ) and size ( D ) of organoids generated from sorted Pten pc−/− LSC med cells after 10 days of culture in medium containing DMSO or 1 nM JQ-1 and 1 nM CX-6258, alone or combined, as indicated. Data were normalized to the control (DMSO) condition (biological replicates, n = 5 independent experiments). ** p < 0.01; *** p < 0.001; **** p < 0.0001 (one-way ANOVA and Dunnett post hoc test). Exact p values are reported in Appendix Table . ( E , F ) Enrichment of various epithelial cell signatures ( E ) and LSC med subpopulation signatures ( F ) in <t>HPV-10,</t> PC-3, DU145, LNCaP, and 22Rv1 cell lines (Data Ref: Wang et al, ). ( G ) Enrichment of CRPC-AR, CRPC-WNT, CRPC-NE, and CRPC-SCL human tumoral subtypes signatures (Dataset ) in HPV-10, PC-3, DU145, LNCaP, and 22Rv1 cell lines. ( H ) Human HPV-10 cells were treated for 72 h with 1 µM JQ-1 and 1 µM CX-6258, alone or combined (as indicated), then the number of adherent cells was counted (biological replicates, n = 4 independent experiments). The data were normalized to the control condition (DMSO). ** p < 0.01; *** p < 0.001 (one-way ANOVA and Dunnett post hoc test). Exact p values are reported in Appendix Table . ( I ) Images of HPV-10 cells after 72 h of treatment. ( J ) The viability of HPV-10 cells (adherent + in suspension) was determined by trypan blue staining (biological replicates, n = 4 independent experiments). ns not significant; * p < 0.05 (one-way ANOVA and Dunnett post hoc test). Exact p values are reported in Appendix Table . ( K , L ) Same as ( H , J ) with PC-3 cells (biological replicates, n = 4 independent experiments). ns not significant; * p < 0.05, ** p < 0.01; *** p < 0.001 (one-way ANOVA and Dunnett post hoc test). Exact p values are reported in Appendix Table . ( M ) Tumorsphere-forming capacity of HPV-10 cells in medium containing DMSO or 1 µM JQ-1 and 1 µM CX - 6258, alone or combined as indicated. Data were normalized to the DMSO condition (biological replicates, n = 3 independent experiments). *** p < 0.001 (one-way ANOVA and Dunnett post hoc test). Exact p values are reported in Appendix Table . All error bars in this figure represent SD. .
Human Ca Ii, supplied by R&D Systems, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/human ca ii/product/R&D Systems
Average 94 stars, based on 1 article reviews
human ca ii - by Bioz Stars, 2026-05
94/100 stars
  Buy from Supplier

93
Addgene inc ca v 2 1
(A) Structural representation of DI–DII PD interface in Ca V 2.1-WT and Ca V 2.1-T698F mutant. Possible π-H and π-π quadrangle interaction in Ca V 2.1-T698F mutant shown as dotted lines. (B) Aligned amino acid sequences of DIIS6, DIIP2, and DIP1 PD helices from human (h) and mouse (m) L-type (Ca V 1.1–1.4) and Ca V 2 (2.1–2.3) channels. Conserved and unique residues participating in π-H and π-π quadrangle interactions are highlighted. (C) Representative whole-cell current traces of Ca V 2.1-WT, Ca V 2.1-T698F, and Ca V 1.2-F737T mutants coexpressed with β 1 b in tsA-201 cells before (P1) or after (P2) DPP to 100 mV. Voltage protocol is represented in dotted box above. (D) Mean fitted plots of Ca V 2.1-WT, Ca V 2.1-T698F, and Ca V 1.2-F737T mutants in response to DPP ranging from 0 to 180 mV. Cell numbers are represented in brackets. (E) Bar plots display the maximum VDF at 120 mV DPP for Ca V 2.1-WT, Ca V 2.1-T698F, and Ca V 1.2-F737T mutants. Unpaired Student’s t-test used statistical significance. All plots represent mean ± SEM. *p ≤ 0.05, **p ≤ 0.01, ***p ≤ 0.001, **p < 0.0001, ns, p > 0.05 (non-significant).
Ca V 2 1, supplied by Addgene inc, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/ca v 2 1/product/Addgene inc
Average 93 stars, based on 1 article reviews
ca v 2 1 - by Bioz Stars, 2026-05
93/100 stars
  Buy from Supplier

Image Search Results


( A , B ) Expression per Pten pc−/− LSC med cell subpopulation ( A ) and UMAP projection ( B ) of Pim1 . ( C , D ) Number ( C ) and size ( D ) of organoids generated from sorted Pten pc−/− LSC med cells after 10 days of culture in medium containing DMSO or 1 nM JQ-1 and 1 nM CX-6258, alone or combined, as indicated. Data were normalized to the control (DMSO) condition (biological replicates, n = 5 independent experiments). ** p < 0.01; *** p < 0.001; **** p < 0.0001 (one-way ANOVA and Dunnett post hoc test). Exact p values are reported in Appendix Table . ( E , F ) Enrichment of various epithelial cell signatures ( E ) and LSC med subpopulation signatures ( F ) in HPV-10, PC-3, DU145, LNCaP, and 22Rv1 cell lines (Data Ref: Wang et al, ). ( G ) Enrichment of CRPC-AR, CRPC-WNT, CRPC-NE, and CRPC-SCL human tumoral subtypes signatures (Dataset ) in HPV-10, PC-3, DU145, LNCaP, and 22Rv1 cell lines. ( H ) Human HPV-10 cells were treated for 72 h with 1 µM JQ-1 and 1 µM CX-6258, alone or combined (as indicated), then the number of adherent cells was counted (biological replicates, n = 4 independent experiments). The data were normalized to the control condition (DMSO). ** p < 0.01; *** p < 0.001 (one-way ANOVA and Dunnett post hoc test). Exact p values are reported in Appendix Table . ( I ) Images of HPV-10 cells after 72 h of treatment. ( J ) The viability of HPV-10 cells (adherent + in suspension) was determined by trypan blue staining (biological replicates, n = 4 independent experiments). ns not significant; * p < 0.05 (one-way ANOVA and Dunnett post hoc test). Exact p values are reported in Appendix Table . ( K , L ) Same as ( H , J ) with PC-3 cells (biological replicates, n = 4 independent experiments). ns not significant; * p < 0.05, ** p < 0.01; *** p < 0.001 (one-way ANOVA and Dunnett post hoc test). Exact p values are reported in Appendix Table . ( M ) Tumorsphere-forming capacity of HPV-10 cells in medium containing DMSO or 1 µM JQ-1 and 1 µM CX - 6258, alone or combined as indicated. Data were normalized to the DMSO condition (biological replicates, n = 3 independent experiments). *** p < 0.001 (one-way ANOVA and Dunnett post hoc test). Exact p values are reported in Appendix Table . All error bars in this figure represent SD. .

Journal: EMBO Molecular Medicine

Article Title: Targeting pre-existing club-like cells in prostate cancer potentiates androgen deprivation therapy

doi: 10.1038/s44321-026-00375-y

Figure Lengend Snippet: ( A , B ) Expression per Pten pc−/− LSC med cell subpopulation ( A ) and UMAP projection ( B ) of Pim1 . ( C , D ) Number ( C ) and size ( D ) of organoids generated from sorted Pten pc−/− LSC med cells after 10 days of culture in medium containing DMSO or 1 nM JQ-1 and 1 nM CX-6258, alone or combined, as indicated. Data were normalized to the control (DMSO) condition (biological replicates, n = 5 independent experiments). ** p < 0.01; *** p < 0.001; **** p < 0.0001 (one-way ANOVA and Dunnett post hoc test). Exact p values are reported in Appendix Table . ( E , F ) Enrichment of various epithelial cell signatures ( E ) and LSC med subpopulation signatures ( F ) in HPV-10, PC-3, DU145, LNCaP, and 22Rv1 cell lines (Data Ref: Wang et al, ). ( G ) Enrichment of CRPC-AR, CRPC-WNT, CRPC-NE, and CRPC-SCL human tumoral subtypes signatures (Dataset ) in HPV-10, PC-3, DU145, LNCaP, and 22Rv1 cell lines. ( H ) Human HPV-10 cells were treated for 72 h with 1 µM JQ-1 and 1 µM CX-6258, alone or combined (as indicated), then the number of adherent cells was counted (biological replicates, n = 4 independent experiments). The data were normalized to the control condition (DMSO). ** p < 0.01; *** p < 0.001 (one-way ANOVA and Dunnett post hoc test). Exact p values are reported in Appendix Table . ( I ) Images of HPV-10 cells after 72 h of treatment. ( J ) The viability of HPV-10 cells (adherent + in suspension) was determined by trypan blue staining (biological replicates, n = 4 independent experiments). ns not significant; * p < 0.05 (one-way ANOVA and Dunnett post hoc test). Exact p values are reported in Appendix Table . ( K , L ) Same as ( H , J ) with PC-3 cells (biological replicates, n = 4 independent experiments). ns not significant; * p < 0.05, ** p < 0.01; *** p < 0.001 (one-way ANOVA and Dunnett post hoc test). Exact p values are reported in Appendix Table . ( M ) Tumorsphere-forming capacity of HPV-10 cells in medium containing DMSO or 1 µM JQ-1 and 1 µM CX - 6258, alone or combined as indicated. Data were normalized to the DMSO condition (biological replicates, n = 3 independent experiments). *** p < 0.001 (one-way ANOVA and Dunnett post hoc test). Exact p values are reported in Appendix Table . All error bars in this figure represent SD. .

Article Snippet: HPV-10 , ATCC , CRL-2220 RRID: CVCL_3495.

Techniques: Expressing, Generated, Control, Suspension, Staining

( A , B ) Dose-response of JQ-1 ( A ) and CX-6258 ( B ) on the number of organoids formed by sorted Pten pc−/− LSC med cells. Data are normalized to the DMSO condition (biological replicates, n = 5 ( A ) and n = 4 ( B ) independent experiments). **** p < 0.0001 versus DMSO (ANOVA analysis and Dunnett’s post hoc test). Exact p values are reported in Appendix Table . ( C ) Expression of FOSL1 and PIM1 in human HPV-10 cells determined by RT-qPCR. The results are normalized to the values obtained in LNCaP cells, represented by the horizontal dotted line (biological replicates, n = 3 independent experiments). * p < 0.05 versus LNCaP cells (unpaired t -test with Welch’s correction), p = 0.0157 ( FOSL1 ), p = 0.0278 ( PIM1 ). ( D ) Dose-response of JQ-1 and CX-6258 on the number of adherent HPV-10 cells. Data were normalized to the DMSO condition (each dot is the average of three biological replicates). **** p < 0.0001 versus DMSO (ordinary two-way ANOVA with Šídák multiple comparisons test). Exact p values are reported in Appendix Table . ( E – H ) Human PC-3 ( E , F ) and HPV-10 ( G , H ) cells were treated with T5224-PROTAC (‘PROTAC’) at 0, 8, and 24 h. The cells were collected at 48 h. The cell number ( E , G ) and cell viability (adherent + in suspension) ( F , H ) were determined by trypan blue staining (biological replicates, n = 4 independent experiments). The data were normalized to DMSO (control condition). * p < 0.05, ** p < 0.01 (ANOVA analysis and Dunn’s post hoc test). ( I ) Human PC-3 cells were treated with siRNA (siScrambled or three different FOSL1 siRNA, as indicated) for 6 h and the cells were collected at 48 h. The expression of FOSL1 was measured by RT-qPCR (biological replicates, n = 2 independent experiments). The data were normalized to siScrambled (control condition). The three siRNA FOSL1 showed similar efficacy. **** p < 0.0001 (ANOVA analysis and Dunnett’s post hoc test). Exact p values are reported in Appendix Table . ( J – L ) Human PC-3 cells were treated with siScrambled or siFOSL1(1) for 6 h and the cells were collected at 72 h. Cell number ( J ) and cell viability (adherent + in suspension) ( K ) were determined by trypan blue staining. The expression of FOSL1 ( L ) was measured by RT-qPCR. The data are normalized to siScrambled (biological replicates, n = 3 independent experiments). ** p < 0.01, *** p < 0.001, **** p < 0.0001 (two-tailed t -test). Exact p values are reported in Appendix Table . All error bars in this figure represent SD.

Journal: EMBO Molecular Medicine

Article Title: Targeting pre-existing club-like cells in prostate cancer potentiates androgen deprivation therapy

doi: 10.1038/s44321-026-00375-y

Figure Lengend Snippet: ( A , B ) Dose-response of JQ-1 ( A ) and CX-6258 ( B ) on the number of organoids formed by sorted Pten pc−/− LSC med cells. Data are normalized to the DMSO condition (biological replicates, n = 5 ( A ) and n = 4 ( B ) independent experiments). **** p < 0.0001 versus DMSO (ANOVA analysis and Dunnett’s post hoc test). Exact p values are reported in Appendix Table . ( C ) Expression of FOSL1 and PIM1 in human HPV-10 cells determined by RT-qPCR. The results are normalized to the values obtained in LNCaP cells, represented by the horizontal dotted line (biological replicates, n = 3 independent experiments). * p < 0.05 versus LNCaP cells (unpaired t -test with Welch’s correction), p = 0.0157 ( FOSL1 ), p = 0.0278 ( PIM1 ). ( D ) Dose-response of JQ-1 and CX-6258 on the number of adherent HPV-10 cells. Data were normalized to the DMSO condition (each dot is the average of three biological replicates). **** p < 0.0001 versus DMSO (ordinary two-way ANOVA with Šídák multiple comparisons test). Exact p values are reported in Appendix Table . ( E – H ) Human PC-3 ( E , F ) and HPV-10 ( G , H ) cells were treated with T5224-PROTAC (‘PROTAC’) at 0, 8, and 24 h. The cells were collected at 48 h. The cell number ( E , G ) and cell viability (adherent + in suspension) ( F , H ) were determined by trypan blue staining (biological replicates, n = 4 independent experiments). The data were normalized to DMSO (control condition). * p < 0.05, ** p < 0.01 (ANOVA analysis and Dunn’s post hoc test). ( I ) Human PC-3 cells were treated with siRNA (siScrambled or three different FOSL1 siRNA, as indicated) for 6 h and the cells were collected at 48 h. The expression of FOSL1 was measured by RT-qPCR (biological replicates, n = 2 independent experiments). The data were normalized to siScrambled (control condition). The three siRNA FOSL1 showed similar efficacy. **** p < 0.0001 (ANOVA analysis and Dunnett’s post hoc test). Exact p values are reported in Appendix Table . ( J – L ) Human PC-3 cells were treated with siScrambled or siFOSL1(1) for 6 h and the cells were collected at 72 h. Cell number ( J ) and cell viability (adherent + in suspension) ( K ) were determined by trypan blue staining. The expression of FOSL1 ( L ) was measured by RT-qPCR. The data are normalized to siScrambled (biological replicates, n = 3 independent experiments). ** p < 0.01, *** p < 0.001, **** p < 0.0001 (two-tailed t -test). Exact p values are reported in Appendix Table . All error bars in this figure represent SD.

Article Snippet: HPV-10 , ATCC , CRL-2220 RRID: CVCL_3495.

Techniques: Expressing, Quantitative RT-PCR, Suspension, Staining, Control, Two Tailed Test

(A) Structural representation of DI–DII PD interface in Ca V 2.1-WT and Ca V 2.1-T698F mutant. Possible π-H and π-π quadrangle interaction in Ca V 2.1-T698F mutant shown as dotted lines. (B) Aligned amino acid sequences of DIIS6, DIIP2, and DIP1 PD helices from human (h) and mouse (m) L-type (Ca V 1.1–1.4) and Ca V 2 (2.1–2.3) channels. Conserved and unique residues participating in π-H and π-π quadrangle interactions are highlighted. (C) Representative whole-cell current traces of Ca V 2.1-WT, Ca V 2.1-T698F, and Ca V 1.2-F737T mutants coexpressed with β 1 b in tsA-201 cells before (P1) or after (P2) DPP to 100 mV. Voltage protocol is represented in dotted box above. (D) Mean fitted plots of Ca V 2.1-WT, Ca V 2.1-T698F, and Ca V 1.2-F737T mutants in response to DPP ranging from 0 to 180 mV. Cell numbers are represented in brackets. (E) Bar plots display the maximum VDF at 120 mV DPP for Ca V 2.1-WT, Ca V 2.1-T698F, and Ca V 1.2-F737T mutants. Unpaired Student’s t-test used statistical significance. All plots represent mean ± SEM. *p ≤ 0.05, **p ≤ 0.01, ***p ≤ 0.001, **p < 0.0001, ns, p > 0.05 (non-significant).

Journal: bioRxiv

Article Title: L-type channel voltage-dependent facilitation results from asymmetric π-H and π-π quadrangle interactions at DI–DII domains

doi: 10.64898/2026.01.23.701029

Figure Lengend Snippet: (A) Structural representation of DI–DII PD interface in Ca V 2.1-WT and Ca V 2.1-T698F mutant. Possible π-H and π-π quadrangle interaction in Ca V 2.1-T698F mutant shown as dotted lines. (B) Aligned amino acid sequences of DIIS6, DIIP2, and DIP1 PD helices from human (h) and mouse (m) L-type (Ca V 1.1–1.4) and Ca V 2 (2.1–2.3) channels. Conserved and unique residues participating in π-H and π-π quadrangle interactions are highlighted. (C) Representative whole-cell current traces of Ca V 2.1-WT, Ca V 2.1-T698F, and Ca V 1.2-F737T mutants coexpressed with β 1 b in tsA-201 cells before (P1) or after (P2) DPP to 100 mV. Voltage protocol is represented in dotted box above. (D) Mean fitted plots of Ca V 2.1-WT, Ca V 2.1-T698F, and Ca V 1.2-F737T mutants in response to DPP ranging from 0 to 180 mV. Cell numbers are represented in brackets. (E) Bar plots display the maximum VDF at 120 mV DPP for Ca V 2.1-WT, Ca V 2.1-T698F, and Ca V 1.2-F737T mutants. Unpaired Student’s t-test used statistical significance. All plots represent mean ± SEM. *p ≤ 0.05, **p ≤ 0.01, ***p ≤ 0.001, **p < 0.0001, ns, p > 0.05 (non-significant).

Article Snippet: In experiments involving P/Q-type currents, the cDNA of Ca V 2.1 (α 1A , human, Addgene ID: 140575 ) was co-transfected with β 1 b at a 1:0.75 ratio.

Techniques: Mutagenesis

(A) Aligned amino acid sequences of DIIS6, DIIP2, and DIP1 PD helices from rat (r) and rabbit (rb) L-type (Ca V 1.1–1.4) and Ca V 2 (2.1–2.3) channels. Conserved and unique residues participating in the π-H and π-π quadrangle interactions are highlighted. (B and C) Representative whole-cell current traces (top) with Current density (pA/pF) and normalized conductance (G/G max ) vs. voltage plots (below) of WT or mutants of Ca V 1.2/Ca V 2.1 channels. Voltage protocol is represented in dotted box above. Insets display half-maximal activation voltages. (D and E) Normalized current traces (left) of WT and mutant Ca V 1.2/Ca V 2.1 channels at 0 mV showing channel inactivation. Time constant of inactivation (τ) plots (right) from exponential fits of 0 mV traces. All plots represent mean ± SEM (cell numbers in brackets). Unpaired Student’s t-test used for statistical significance. *p ≤ 0.05, **p ≤ 0.01, ns, non-significant.

Journal: bioRxiv

Article Title: L-type channel voltage-dependent facilitation results from asymmetric π-H and π-π quadrangle interactions at DI–DII domains

doi: 10.64898/2026.01.23.701029

Figure Lengend Snippet: (A) Aligned amino acid sequences of DIIS6, DIIP2, and DIP1 PD helices from rat (r) and rabbit (rb) L-type (Ca V 1.1–1.4) and Ca V 2 (2.1–2.3) channels. Conserved and unique residues participating in the π-H and π-π quadrangle interactions are highlighted. (B and C) Representative whole-cell current traces (top) with Current density (pA/pF) and normalized conductance (G/G max ) vs. voltage plots (below) of WT or mutants of Ca V 1.2/Ca V 2.1 channels. Voltage protocol is represented in dotted box above. Insets display half-maximal activation voltages. (D and E) Normalized current traces (left) of WT and mutant Ca V 1.2/Ca V 2.1 channels at 0 mV showing channel inactivation. Time constant of inactivation (τ) plots (right) from exponential fits of 0 mV traces. All plots represent mean ± SEM (cell numbers in brackets). Unpaired Student’s t-test used for statistical significance. *p ≤ 0.05, **p ≤ 0.01, ns, non-significant.

Article Snippet: In experiments involving P/Q-type currents, the cDNA of Ca V 2.1 (α 1A , human, Addgene ID: 140575 ) was co-transfected with β 1 b at a 1:0.75 ratio.

Techniques: Activation Assay, Mutagenesis